Skip to main content
. 2021 Jun 21;4(6):e2112210. doi: 10.1001/jamanetworkopen.2021.12210

Table 1. Prevalence of Preventive Aspirin Use by Cardiovascular Disease and Diabetes Status According to Demographic and Clinical Characteristics Among 7103 US Adults Aged 60 Years or Older, NHANES 2011-2018a.

Characteristic History of CVD (n = 1496)b No history of CVD
Diabetes (n = 1378) No diabetes (n = 4229)
No ASA ASA P value No ASA ASA P value No ASA ASA P value
Age group, y
60-69 37.0 (2.9) 40.1 (2.1) .047 56.6 (2.8) 53.8 (2.4) .61 62.1 (1.5) 50.3 (2.2) <.001
70-79 31.6 (2.8) 36.3 (1.7) 30.6 (2.5) 33.6 (2.6) 25.7 (1.3) 31.4 (1.5)
≥80 31.4 (2.3) 23.6 (1.6) 12.8 (1.3) 12.6 (1.5) 12.1 (0.8) 18.3 (1.5)
Mean (SD) age, y 72.2 (0.4) 71.6 (0.3) .23 69.1 (0.4) 69.5 (0.3) .41 68.4 (0.2) 70.2 (0.3) <.001
Sex
Male 47.8 (2.9) 61.1 (2.5) <.001 43.4 (2.9) 54.0 (2.5) .007 40.3 (1.3) 40.7 (1.6) .85
Female 52.2 (2.9) 38.9 (2.5) <.001 56.6 (2.9) 46.0 (2.5) .007 59.7 (1.3) 59.3 (1.6) .85
Race/ethnicity
White 73.6 (2.4) 78.3 (1.8) .27 58.7 (3.4) 64.7 (2.8) .17 76.4 (1.6) 82.7 (1.5) <.001
Black 9.5 (1.3) 8.3 (1.0) 14.7 (1.9) 13.0 (1.8) 8.3 (0.9) 7.8 (0.9)
Mexican American 3.6 (0.9) 2.9 (0.7) 9.7 (2.1) 7.1 (1.2) 4.2 (0.6) 2.6 (0.5)
Asian 2.8 (0.7) 3.0 (0.4) 8.2 (1.5) 6.4 (1.0) 5.3 (0.6) 2.0 (0.3)
Other 10.5 (1.9) 7.5 (1.3) 8.6 (1.3) 8.9 (1.5) 5.8 (0.6) 4.8 (0.7)
Education level
<High school 23.9 (2.1) 19.5 (1.9) .05 24.7 (2.3) 18.7 (1.8) .07 14.4 (1.1) 12.6 (1.2) .33
High school 30.4 (3.0) 25.5 (1.9) 20.6 (2.2) 27.0 (2.9) 22.8 (1.3) 24.3 (1.8)
>High school 45.6 (3.0) 55.0 (2.2) 54.7 (2.9) 54.3 (2.6) 62.7 (1.5) 63.2 (2.1)
Smoking
Current 16.2 (2.4) 14.0 (1.8) .75 9.3 (2.0) 8.2 (1.4) .56 12.4 (0.9) 8.7 (1.1) .06
Former 44.3 (3.5) 44.7 (2.5) 38.6 (2.8) 42.8 (2.6) 34.3 (1.5) 37.3 (2.1)
Never 39.5 (3.0) 41.3 (2.4) 52.1 (2.4) 49.0 (2.8) 53.3 (1.4) 54.1 (2.0)
Metabolic status, mean (SD)
BMI 30.2 (0.5) 29.8 (0.3) .54 31.4 (0.4) 32.1 (0.4) .25 28.2 (0.2) 28.9 (0.3) .04
Waist circumference, cm 106.1 (1.3) 106.4 (0.9) .84 107.6 (0.8) 110.2 (0.8) .04 99.8 (0.5) 102.1 (0.6) .002
HbA1c, % 6.31 (0.09) 6.20 (0.05) .28 7.06 (0.09) 7.07 (0.08) .95 5.62 (0.01) 5.67 (0.01) .01
Diabetes duration, y NA NA NA 12.5 (0.6) 13.9 (0.6) .16 NA NA NA
Comorbidities
Coronary heart disease 63.8 (2.9) 80.6 (1.8) <.001 NA NA NA NA NA NA
Stroke 52.6 (3.3) 31.4 (2.2) <.001 NA NA NA NA NA NA
Congestive heart failure 24.6 (2.1) 23.6 (1.7) .72 5.7 (1.4) 4.0 (0.9) .30 1.5 (0.3) 2.3 (0.4) .11
Myocardial Infarction 38.7 (2.7) 48.1 (2.1) .009 NA NA NA NA NA NA
Angina 4.4 (1.1) 3.8 (0.9) .70 NA NA NA NA NA NA
Obesity 45.3 (3.4) 44.5 (2.8) .85 51.1 (2.8) 57.9 (2.8) .11 32.7 (1.5) 36.7 (1.8) .06
Hypertension 72.3 (2.8) 77.3 (2.0) .15 68.5 (3.6) 76.3 (2.0) .06 42.9 (1.6) 61.4 (2.1) <.001
Hypercholesterolemia 76.9 (2.5) 84.6 (1.5) .008 72.9 (2.5) 77.8 (2.4) .19 53.4 (1.2) 68.8 (1.6) <.001
Family history of MI prior to age 50 23.9 (3.1) 22.9 (1.9) .78 12.8 (2.2) 15.1 (2.1) .45 11.4 (0.8) 13.9 (1.4) .10

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CVD, cardiovascular disease; HbA1c, hemoglobin A1c; MI, myocardial infarction; NA, not available; NHANES, National Health and Nutrition Examination Survey.

a

Nationally representative estimates shown as % (linearized SE), unless indicated otherwise, percentages within columns are shown.

b

Includes adults both with or without diabetes. History of CVD includes myocardial infarction, stroke, angina, and coronary heart disease.